Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Fighting the battle against disease - Leeds researchers take on the world

02.03.2006


Every year at least six million people die from TB, malaria or HIV. Leeds researchers will play a major role in the fight against the world’s three biggest killers in a £5m programme spanning countries from China to Nepal and Bangladesh to Uganda.



The five-year project will help ensure that the best treatments reach those in most need as quickly as possible, and that effective healthcare systems are established to prevent the spread of disease.

“Our vision is to contribute at a global level to a better understanding of ways to combat communicable diseases,” said Dr John Walley, co-director of COMDIS. Dr Walley and co-director Dr James Newell will work with research partners, national TB, AIDS and malaria programmes, patients, doctors and policy makers across Asia and Africa to develop practical and affordable improvements - or ‘interventions’ - to save lives from these devastating diseases. “An ‘intervention’ can both cure patients and prevent the spread of disease,” said Dr Walley.


“Take for example, improving the way people take their TB medication. If they take it properly, they’ll be cured and won’t pass it on to other people. The intervention could be better communication, better education or improving the way health systems pick up and care for people with health problems.”

Effective healthcare, with timely and high quality interventions, needs efficient and integrated healthcare systems. But in many overburdened countries these do not exist - the challenge for the Nuffield team is to design research leading to solutions that are practical in real-life situations. “Although solutions are out there for disease control, the major problem is being able to use these in ways that are responsive to patient needs, cost-effective and sustainable,” said Dr Walley.

The COMDIS programme will test ways to improve the quality and coverage of healthcare for the poor and vulnerable, which could include anything from community based TB care in remote areas or insecticide-treated plastic for displaced people, to interactive theatre exploring the causes of stigma and discrimination associated with TB, which deter people with the disease from coming forward for treatment.

The group prioritise situations where resources exist from national and international agencies to help improve healthcare, and focus on the ‘bottlenecks’ - what is preventing it being successfully carried out. Solutions are trialled and monitored for effectiveness, and best practice is promoted in both research publications and to the people who will need to use them.

“If we can demonstrate the effectiveness of new strategies in reducing health equalities in a cost-neutral way, they are more likely to be taken up by communicable disease programmes,” said Dr Newell. “Improving quality by addressing access, efficiency, equity and effectiveness can help programmes achieve their goals without heavy investment. We believe that the quality, relevance and timeliness of our evidence can dramatically alter the approach and results of reaching the poor.”

Their successful approach to development is based on ten years of public health programme design and implementation experience, ensuring that the interventions are sustainable, affordable and acceptable to patients, health workers and managers. “Our strength is the longstanding relationship and track record we have with in-country disease control programmes,” said Dr Newell. “Rather than lip service, national control programmes are involved throughout.”

Many of their most fruitful relationships on the ground began during the Nuffield centre for international health and development’s tuberculosis research programme, which ends the day that COMDIS begins. The group worked closely with the Pakistan national tuberculosis programme providing guidance on how best to roll out DOTS, the World Health Organization TB control strategy. Following pilot projects and a Lancet-published trial, they worked with the TB programme to improve strategic planning, care guidelines and training materials.

The case management guidelines and materials were used in training 100,000 doctors and other health workers involved in TB treatment in Pakistan. As a result the successful treatment rate has since risen from 30 per cent to an average of 82 per cent, curing at least 22,000 more people, who would otherwise have infected another 220,000. Similar work was completed in other countries including China, where their TB diagnosis and care guidelines will be used to train 11,000 doctors.

COMDIS will take a ‘cross-cutting’ approach to develop similar systems for different diseases across different countries - for example, they will apply their experience in TB to HIV care, effectively delivering anti-retroviral treatment in Uganda and Swaziland.

Their embedded approach to research and development means the COMDIS consortium can make the £5m, funded by the department for international development, go a long way. Partners in COMDIS include the Beijing National and Guangxi provincial centres for disease control, the Malaria Consortium in the UK and Africa and BRAC - which provides community healthcare across two-thirds of Bangladesh. Dr Newell stressed: “The involvement of policy makers from the beginning is crucial for researchers to address key operational constraints, and for rapid knowledge dissemination.”

“At first sight there are plenty of solutions to healthcare problems in these countries but the challenge is finding ones that can really work under the difficult conditions seen in developing countries,” said Dr Walley. “COMDIS will make sure that research makes a real difference to a huge number of people.”

Claire Jones | alfa
Further information:
http://reporter.leeds.ac.uk/514/s6.htm

More articles from Health and Medicine:

nachricht Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania

nachricht The strange double life of Dab2
10.01.2017 | University of Miami Miller School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

Im Focus: Newly proposed reference datasets improve weather satellite data quality

UMD, NOAA collaboration demonstrates suitability of in-orbit datasets for weather satellite calibration

"Traffic and weather, together on the hour!" blasts your local radio station, while your smartphone knows the weather halfway across the world. A network of...

Im Focus: Repairing defects in fiber-reinforced plastics more efficiently

Fiber-reinforced plastics (FRP) are frequently used in the aeronautic and automobile industry. However, the repair of workpieces made of these composite materials is often less profitable than exchanging the part. In order to increase the lifetime of FRP parts and to make them more eco-efficient, the Laser Zentrum Hannover e.V. (LZH) and the Apodius GmbH want to combine a new measuring device for fiber layer orientation with an innovative laser-based repair process.

Defects in FRP pieces may be production or operation-related. Whether or not repair is cost-effective depends on the geometry of the defective area, the tools...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Solar Collectors from Ultra-High Performance Concrete Combine Energy Efficiency and Aesthetics

16.01.2017 | Trade Fair News

3D scans for the automotive industry

16.01.2017 | Automotive Engineering

Nanoparticle Exposure Can Awaken Dormant Viruses in the Lungs

16.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>